Aratana Therapeutics to Present at Credit Suisse Healthcare Conference

LEAWOOD, Kan., Oct. 30, 2017 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative therapeutics for dogs and cats, plans to present at the Credit Suisse Healthcare Conference on Tuesday, November 7, 2017 at 4:30 p.m. MT in Scottsdale, Ariz.

Interested parties may listen to the webcast live or access the audio link for up to 90 days after the meeting. Presentation slides from the conference will also be available in the Aratana Investor Room.

About Aratana Therapeutics Aratana Therapeutics is a pet therapeutics company focused on licensing, developing and commercializing innovative therapeutics for dogs and cats. Aratana believes that it can leverage the investment in the human biopharmaceutical industry to bring therapeutics to pets in a capital and time efficient manner. The Company's pipeline includes therapeutic candidates targeting pain, inappetence, cancer, viral diseases, allergy and other serious medical conditions.  Aratana believes the development and commercialization of these therapeutics will permit veterinarians and pet owners to manage pets' medical needs safely and effectively, resulting in longer and improved quality of life for pets. For more information, please visit www.aratana.com.

ContactsFor investor inquires: Craig Tooman[email protected] (913) 353-1026

For media inquiries: Rachel Reiff[email protected] (913) 353-1050

View original content with multimedia:http://www.prnewswire.com/news-releases/aratana-therapeutics-to-present-at-credit-suisse-healthcare-conference-300544884.html

SOURCE Aratana Therapeutics, Inc.